Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Applied Dna Scns (NQ: APDN )

7.700 USD -0.110 (-1.41%)
Official Closing Price Updated: 6:51 PM EDT, Oct 23, 2020 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 82,800
Open 7.800
Bid (Size) 7.610 (1)
Ask (Size) 7.890 (2)
Prev. Close 7.810
Today's Range 7.540 - 7.850
52wk Range 0.1680 - 19.69
Shares Outstanding 30,112,057
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Applied DNA Secures $1.0+ Million in COVID-19 Surveillance Testing Annualized Revenue, Builds Sales Pipeline for Test Kit and Testing-as-a-Service
Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the "Company"), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing that enables in vitro diagnostics, pre-clinical nucleic... 
From Business Wire News Releases
Applied DNA Announces Repayment of Secured Convertible Notes
Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the "Company"), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing that enables in vitro diagnostics, pre-clinical nucleic... 
From Business Wire News Releases

Performance

YTD
+73.81%
+73.81%
1 Month
-1.79%
-1.79%
3 Month
-16.76%
-16.76%
6 Month
+15.27%
+15.27%
1 Year
+3292.07%
+3292.07%

More News

Read More
Applied DNA Signs Master Services Agreement with Stony Brook University Hospital for COVID-19 Diagnostic Assay Kit and Automated Systems, Receives Initial Purchase Order
From Business Wire News Releases
Applied DNA Enters into Supply Agreement with ITW Pillar Technologies to Bring CertainT® Platform to Textiles Including Those Used in Personal Protective Equipment
From Business Wire News Releases
Applied DNA and Takis Biotech/Evvivax to Launch Clinical Trial for Veterinary Use of Linear COVID-19 Vaccine Candidate
From Business Wire News Releases
Applied DNA to Present at H.C. Wainwright 22nd Annual Global Investment Conference on September 15
From Business Wire News Releases
Applied DNA Provides Update on Status of New York State Laboratory Permit for Clinical Labs Subsidiary
From Business Wire News Releases
Applied DNA Positions LinearDNA™ Platform as the Next Generation Manufacturing Platform for Adeno-Associated Virus-based Gene Therapies Through New Patent Filing
From Business Wire News Releases
Applied DNA Receives Notice of Allowance on Second Patent Protecting Proprietary DNA Transfer System for Large-Scale Cotton Tagging
From Business Wire News Releases
Applied DNA Reports Fiscal Third Quarter 2020 Financial Results
From Business Wire News Releases
Stocks Showing Market Leadership: Applied Dna Sciences Earns 93 RS Rating
From Investor's Business Daily
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.